🇺🇸 FDA
Patent

US 8784849

Hydroxyapatite-targeting poly(ethylene glycol) and related polymers

granted A61KA61K31/715A61K47/18

Quick answer

US patent 8784849 (Hydroxyapatite-targeting poly(ethylene glycol) and related polymers) held by Nektar Therapeutics expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/715, A61K47/18, A61K47/24, A61K47/60